| Project/Area Number |
16K19465
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Respiratory organ internal medicine
|
|---|
| Research Institution | Keio University |
|---|
Principal Investigator |
|
|---|
| Research Collaborator |
SOEJIMA Kenzo
YASUDA Hiroyuki
MASUZAWA Keita
ARAI Daisuke
|
|---|
| Project Period (FY) |
2016-04-01 – 2018-03-31
|
| Project Status |
Completed (Fiscal Year 2017)
|
| Budget Amount *help |
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2017: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2016: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
|---|
| Keywords | 肺癌 / 分子標的薬 / 腫瘍内代謝 / imaging massspectrometry / 血管新生阻害薬 |
|---|
| Outline of Final Research Achievements |
We established a xenograft mouse model subcutaneously transplanted with a non-small cell lung cancer cell line. Next, we evaluated Intratumoral metabolism of xenograft mouse model using imaging massspectrometry after administration of angiogenesis inhibitor (BIBF 1120, bevacizumab). As a result of evaluation, BIBF 1120 and bevacizumab showed different effects on blood flow and intratumoral metabolism.
|
